Search for: "Apotex"
Results 521 - 540
of 1,051
Sorted by Relevance
|
Sort by Date
10 Sep 2008, 6:00 pm
Bodnar's actions are directly tied to the Apotex settlement, the Justice Department investigation, and the alleged misstatements and omissions. [read post]
7 Jan 2007, 4:53 pm
Apotex, 439 F.3d 1312, 1313 (Fed. [read post]
15 Sep 2010, 2:40 am
KG v Apotex Pty Ltd (No 2) (Patentology) MoviPrep – US: Salix and Norgine settle with Novel in patent dispute over MoviPrep (Patent Docs) Nexavar (Sorafenib) – India: Nexavar patent infringement suit before Delhi HC goes directly to trial: Bayer v Cipla (Spicy IP) Simcor (Niacin/Simvastatin) – US: Abbott files patent infringement suit against Teva following Para IV challenge (Patent Docs) Vancocin (Vancomycin) – US: ViroPharma sues FDA over generic Vancocin; alleges… [read post]
26 Jul 2010, 3:10 am
In attempt to dislodge the injunction, Apotex has sought patent reexamination. [read post]
8 Jul 2016, 4:00 am
Apotex Inc., 2016 FC 344 at para 13). [read post]
22 Oct 2014, 9:02 pm
In the following case, Apotex v. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
29 Jun 2011, 2:00 am
Apotex (Case No. 06-cv-5571-Rpp (S.D.N.Y.)). (3) 95/001,668 (electronically filed) - U.S. [read post]
14 Apr 2009, 2:04 am
Apotex had earlier made a corporate commitment to export medicines to countries in need. [read post]
29 Jun 2011, 2:00 am
Apotex (Case No. 06-cv-5571-Rpp (S.D.N.Y.)). (3) 95/001,668 (electronically filed) - U.S. [read post]
1 Jun 2007, 9:05 am
Apotex, 06A1131) contends that the Circuit Court failed to apply the Justices' unanimous April 30 ruling overturning the appeals court's method of judging patentability. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
28 Sep 2010, 3:14 pm
(Patent Docs) Paxil (Paroxetine) – US: Mylan granted TRO against GlaxoSmithKline and Apotex prohibiting supply, sale and/or importing of a generic version of Paxil CR (SmartBrief) Zegerid (Omeprazole/Sodium bicarbonate) – US: Patent infringement complaints filed following Paragraph IV certification: Schering-Plough Healthcare Products, Inc. et al. v. [read post]
10 Oct 2008, 5:51 pm
12 Jul 2007, 10:06 pm
By Donald Zuhn -- On Wednesday, the Federal Circuit reversed a District Court judgment that U.S. [read post]
25 Mar 2007, 6:04 pm
By Donald Zuhn --- In an appeal from a District Court judgment of validity, enforceability, and infringement, the Federal Circuit reversed the District Court's finding of validity, holding that U.S. [read post]
22 May 2007, 9:52 pm
By Donald Zuhn -- On Monday, the Federal Circuit denied a combined petition for panel rehearing and rehearing en banc filed by Plaintiff-Appellee Pfizer, Inc. [read post]
27 Feb 2007, 10:27 pm
As we reported last fall, Pfizer previously defeated challenges of the same patent brought by two other generic drug makers, Apotex and Synthon. [read post]
23 Jun 2010, 10:28 pm
Apotex, Inc. et al. [read post]
29 May 2007, 3:42 am
Apotex, Inc. [read post]
